616 results on '"White, Eric S"'
Search Results
152. Lung Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis Exhibit Genome-Wide Differences in DNA Methylation Compared to Fibroblasts from Nonfibrotic Lung
153. miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis
154. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
155. Chitinase 3–Like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis
156. Prostaglandin E2 Inhibits α-Smooth Muscle Actin Transcription during Myofibroblast Differentiation via Distinct Mechanisms of Modulation of Serum Response Factor and Myocardin-related Transcription Factor-A
157. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo
158. Fibronectin EDA Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor Signaling
159. Maternal Infection with Schistosoma japonicum Induces a Profibrotic Response in Neonates
160. Human iPS cell–derived alveolar epithelium repopulates lung extracellular matrix
161. Schistosoma japonicum Soluble Egg Antigens Attenuate Invasion in a First Trimester Human Placental Trophoblast Model
162. Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution
163. The myofibroblast matrix: implications for tissue repair and fibrosis
164. Improved survival in tumor-bearing SCID mice treated with interferon-??-inducible protein 10 (IP-10/CXCL10)
165. A Peripheral Blood Extracellular Matrix Biomarker Signature Predicts Disease Progression In IPF
166. Interleukin-17 Drives Pulmonary Eosinophilia following Repeated Exposure to Aspergillus fumigatus Conidia
167. PTEN Directly Activates the Actin Depolymerization Factor Cofilin-1 During PGE 2 -Mediated Inhibition of Phagocytosis of Fungi
168. Repeated Exposure to Aspergillus fumigatus Conidia Results in CD4 + T Cell-Dependent and -Independent Pulmonary Arterial Remodeling in a Mixed Th1/Th2/Th17 Microenvironment That Requires Interleukin-4 (IL-4) and IL-10
169. Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis
170. Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts
171. Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease
172. The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
173. Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models
174. Extra Domain A Fibronectin Promotes Fibrotic Remodeling In Chronic Cardiac Allograft Rejection
175. Promoter Methylation Downregulates PTEN Expression In IPF Lung Fibroblasts
176. Decellularized Human Lung Slices Implicate The Extracellular Matrix In Directing Fibroblast Phenotypes
177. High-Throughput Plasma Biomarker Analysis In Ipf Reveals An Extracellular Matrix Remodeling Signature
178. Tissue Inhibitor of Matrix-Metalloprotease–1 Predicts Risk of Hepatic Fibrosis in Human Schistosoma japonicum Infection
179. Coevolution of T H 1, T H 2, and T H 17 Responses during Repeated Pulmonary Exposure to Aspergillus fumigatus Conidia
180. Hypermethylation of PTGER2 Confers Prostaglandin E2 Resistance in Fibrotic Fibroblasts from Humans and Mice
181. EDA‐containing cellular fibronectin induces fibroblast differentiation through binding to α 4 β 7 integrin receptor and MAPK/Erk 1/2‐dependent signaling
182. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice
183. An Alternatively-Spliced Isoform Of Fibronectin As A Potential Biomarker In Idiopathic Pulmonary Fibrosis
184. The Fibronectin EDA Splicing Variant Induces Epithelial-mesenchymal Transition In Lung Cancer Cells Through Integrin ±9²1-mediated Activation Of PI3-K And Erk1/2
185. Phosphatase and Tensin Homologue on Chromosome 10 (PTEN) Directs Prostaglandin E2-mediated Fibroblast Responses via Regulation of E Prostanoid 2 Receptor Expression
186. Prostaglandin E2induces fibroblast apoptosis by modulating multiple survival pathways
187. The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation
188. Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis
189. Adoption of Antifibrotic Medications: A Closer Look at the Data.
190. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
191. Erratum: Prostaglandin E2Inhibits Fibroblast Migration by E-Prostanoid 2 Receptor–Mediated Increase in PTEN Activity
192. Activation of Phosphatase and Tensin Homolog on Chromosome 10 Mediates the Inhibition of FcγR Phagocytosis by Prostaglandin E2 in Alveolar Macrophages
193. DRAMATIC RESPONSES TO INFLIXIMAB IN PATIENTS WITH SEVERE CENTRAL NERVOUS SYSTEM SARCOIDOSIS FAILING CYCLOPHOSPHAMIDE AND CORTICOSTEROIDS
194. PGE2 inhibition of TGF-β1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling
195. Current and emerging strategies for the management of sarcoidosis
196. Combinatorial activation of FAK and AKT by transforming growth factor-β1 confers an anoikis-resistant phenotype to myofibroblasts
197. Lung Extracellular Matrix and Fibroblast Function.
198. In vitro generation of human pluripotent stem cell derived lung organoids.
199. Blue journal conference. Aging and susceptibility to lung disease.
200. Infliximab in Sarcoidosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.